News – Page 1161 – Endpoints News

SIGN UP

Chrono gets a $47M round for new tech designed to quell tobacco cravings

9 years ago

Pfizer seeds diabetes upstart AnTolRx with cash and an option deal

9 years ago

Stung by patient deaths, a small Juno study points to a Goldilocks formula for CAR-T

9 years ago

GW Pharma spikes as the latest buyout rumors swirl around cannabinoid pipeline

9 years ago

Protocols: Retrophin shares soar on promising Phase II data; FDA readies Keytruda review for lung cancer

9 years ago

The next breakthrough? MSK’s Sadelain ties up with Fate on off-the-shelf CAR-Ts

9 years ago

Celgene is squeezing the trigger on an early FDA filing for key Agios cancer drug

9 years ago

$1.9B in: Moderna blueprints $100M facility, plans to double the pipeline after a $474M megaround

9 years ago

Alzheimer’s player gets $47M, a new name and a pair of marquee board members

9 years ago

$33M in hand, Rigontec opens an office in Cambridge and sets sights on its first immuno-oncology trial

9 years ago

Protocols: CoLucid shares rocket up on positive migraine PhIII; Sage bags a 'breakthrough' on post-partum depression

9 years ago

Allergan bags an early-stage gene therapy in $60M RetroSense buyout

9 years ago

Allergan CEO Brent Saunders takes a pricing pledge: Predatory practices must end

9 years ago

After landing a $354M payout, Medivation CEO David Hung doesn’t overlook his 2016 bonus

9 years ago

Karyopharm sets a course for the FDA with positive PhIIb multiple myeloma data

9 years ago

AstraZeneca offers some mixed PhIII results for severe asthma, while Roche rival flounders

9 years ago

Novartis’ CAR-T chief Azam is leaving, but pharma giant denies any ‘retreat’ is underway

9 years ago

Protocols: Hillary Clinton takes aim at drug profiteers; Arena spins out a GPCR biotech incubator

9 years ago

Thumbs Up/Thumbs Down: Novartis's retreat leaves plenty of casualties; Biogen orchestrates a shameful media show, and ...

9 years ago

Stroke risk forces Merck to scrap its long-neglected PhIII osteoporosis drug odanacatib

9 years ago

Scoop: Novartis’ retreat on CAR-T includes axing most of its senior execs on the team

9 years ago

Momenta’s failed pancreatic cancer drug is given a midnight funeral

9 years ago

Protocols: Novo chief Sørensen is handing over the reins early; Cytokinetics moves Amgen-partnered heart drug into ...

9 years ago

Roger Tsien, 1952-2016: “I’ve always been attracted to colors”

9 years ago

First page Previous page 1158 1159 116011611162 1163 1164 Next page Last page